Literature DB >> 11587972

Long-acting inhaled beta(2)-agonist therapy in asthma.

J C Kips1, R A Pauwels.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11587972     DOI: 10.1164/ajrccm.164.6.2010107

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.

Authors:  M Delvaux; M Henket; L Lau; P Kange; P Bartsch; R Djukanovic; R Louis
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

Authors:  E H Walters; J A Walters; P W Gibson
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 3.  The role of inhaled long-acting beta-2 agonists in the management of asthma.

Authors:  H William Kelly; Michelle S Harkins; Homer Boushey
Journal:  J Natl Med Assoc       Date:  2006-01       Impact factor: 1.798

Review 4.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes.

Authors:  Jaap Oostendorp; Dirkje S Postma; Haukeline Volders; Hajo Jongepier; Henk F Kauffman; H Marike Boezen; Deborah A Meyers; Eugene R Bleecker; S Adriaan Nelemans; Johan Zaagsma; Herman Meurs
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

Review 6.  Treatment of childhood asthma: how do the available options compare?

Authors:  David Coghlan; Colin Powell
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Human airway contraction and formoterol-induced relaxation is determined by Ca2+ oscillations and Ca2+ sensitivity.

Authors:  Anna-Rebekka Ressmeyer; Yan Bai; Philippe Delmotte; Karl F Uy; Patricia Thistlethwaite; Armando Fraire; Osamu Sato; Mitsuo Ikebe; Michael J Sanderson
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-18       Impact factor: 6.914

Review 8.  [Pulmonary diseases in the elderly. Problems of pharmacotherapy].

Authors:  D Ukena
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

9.  Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.

Authors:  C M Houghton; S J Langley; S D Singh; J Holden; A P Monici Preti; D Acerbi; G Poli; A Woodcock
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 10.  6. Asthma.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.